Rembrandt M&A advised the shareholders of the Dutch BModesto Group, the company active in the parallel import and exclusive distribution of medicines and medical devices in Europe, in the sale to the Irish Uniphar PLC, a global partner for pharmaceutical and medtech manufacturers, working to improve access to medicines for patients in Europe and around the world.
About BModesto Group
BModesto Group’s activities include parallel import and exclusive distribution of medicines, through which the company ensures improved availability and affordability of medicines in Europe. In addition, BModesto Group provides medical devices and comparator drugs for clinical trials and other services through which the company contributes to the development of new medicines. Founded in 2014, the group currently employs over 180 people.
About Uniphar Plc
Uniphar is a global partner for pharmaceutical and medtech manufacturers, working to improve access to medicines for patients in Europe and around the world. With more than 3,000 employees, the group operates in Ireland, the UK, Benelux, Scandinavia and the US. With the acquisition of BModesto Group, Uniphar strengthens its position within the Benelux and Germany and the combined expertise of both companies will contribute to better access to medicines.
Rembrandt M&A
Advised in the sale of
BModesto Group
to